Icad Inc ICAD

NAS: ICAD | ISIN: US44934S2068   16/07/2025
3,870 USD (+3,75%)
(+3,75%)   16/07/2025

10 juni 2025 · $TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of SVT, SSBK, LNSR, iCAD to Protect Their Rights · Persbericht

10 juni 2025 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, LNSR, ICAD on Behalf of Shareholders · Persbericht

2 juni 2025 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ICAD, BSGM, SSBK on Behalf of Shareholders · Persbericht

2 juni 2025 · $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger: SSBK, LNSR, iCAD and BSGM · Persbericht

22 mei 2025 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, RDUS, SSBK on Behalf of Shareholders · Persbericht

29 april 2025 · Clinical AI Platforms Expand Globally Amid Regulatory and Market Tailwinds · Persbericht

11 januari 2022 · iCAD Announces the Appointment of New Members to its Board of Directors · Persbericht

15 maart 2021 · iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography · Persbericht

8 maart 2021 · New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting · Persbericht

4 maart 2021 · iCAD to Participate in the Cowen 41st Annual Health Care Conference · Persbericht

3 maart 2021 · iCAD Announces Pricing of $22.0 Million Public Offering of Common Stock · Persbericht

2 maart 2021 · iCAD Announces Proposed Public Offering of Common Stock · Persbericht

24 februari 2021 · iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2020 · Persbericht

16 februari 2021 · iCAD to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference · Persbericht

19 januari 2021 · iCAD to Participate in B. Riley Securities Virtual Oncology Investor Conference · Persbericht

6 januari 2021 · iCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event · Persbericht

Mijn selecties